Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Marie Skłodowska-Curie Action · Running

GlycoAxis Training the next generation of scientists on cell surface Glycans from Gram-negative gut microbiota as molecular keys to decOde the gut-immune-brain Axis

Coordinator
Universita Degli Studi Di Napoli Federico Ii, Italy
Runs
1 January 2027 to 31 December 2030
Status
Running
EU funding
€3.9m
Total cost
—
Partners
16 organisations in 8 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101311186

What the project is doing

In the project's own words, from its summary on CORDIS.

GlycoAxis aims to train 13 Doctoral Candidates (DCs) to address a major blind spot in brain-health research: the molecular mediators linking gut microbiota to neuroinflammation. Across over 600 brain diseases, immune-inflammatory pathways and gut microbial imbalances co-occur, giving rise to the concept of a gut-immune-brain axis (GIBA). Yet current studies remain largely correlative and fail to identify the molecular effectors of this dialogue.

GlycoAxis places Gram-negative surface glycans, lipopolysaccharides and capsular polysaccharides, as central molecular keys to decode the GIBA. These surface-exposed and structurally diverse molecules drive immune sensing, cross biological barriers, and can be chemically tagged, imaged and profiled, making them ideal candidates for functional and translational exploration. Only a coordinated effort combining chemistry, structural biology, microbiology, immunology, and neurobiology can tackle the complexity of GIBA and translate discoveries into innovation.

GlycoAxis integrates these disciplines into a multisectoral and interdisciplinary network to train DCs while delivering tangible scientific and technological outputs. Through its multidimensional approach, it will (i) establish the molecular framework of gut bacterial glycans relevant to the brain; (ii) integrate advanced (neuro)immunological models to clarify how glycans are sensed by host receptors and modulate neuroinflammation; (iii) produce translational platforms for glycan profiling, imaging and biomarker discovery, paving the way for innovative diagnostics in brain health.

Each DC will pursue an individual research project bridging fundamental and translational science, enriched by secondments with industrial partners. By moving the field from correlation to causation, GlycoAxis will strengthen Europe leadership at the chemistry-neuroscience interface and equip a new generation of scientists with cutting-edge skills for careers in academia and industry.

Topics

Who is involved

OrganisationCityCountryRole
Universita Degli Studi Di Napoli Federico IiNapoliItalyCoordinator
Coris Bioconcept SprlGemblouxBelgiumAssociatedpartner
Universite De NamurNamurBelgiumParticipant
Universitaet BernBernSwitzerlandParticipant
Freie Universitaet BerlinBerlinGermanyAssociatedpartner
Glycouniverse GmbH & Co. Kommanditgesellschaft Auf AktienPotsdamGermanyParticipant
Ludwig-Maximilians-Universitaet MuenchenPlaneggGermanyParticipant
Universitaet MuensterMuensterGermanyParticipant
Agencia Estatal Consejo Superior De Investigaciones CientificasMadridSpainParticipant
Universidad Complutense De MadridMadridSpainAssociatedpartner
Helsingin YliopistoHelsinkiFinlandParticipant
Biomimx SRLMilanoItalyParticipant
Biopox SRLNapoliItalyAssociatedpartner
Innovation Acta SRLSienaItalyAssociatedpartner
Universite Du LuxembourgEsch-Sur-AlzetteLuxembourgParticipant
The University of ManchesterManchesterUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI